HAOHAI BIOTEC: Overseas Regulatory Announcement - Legal Opinion from Shanghai Jintiancheng Law Firm regarding the adjustment of the granted quantity and granted price of the 2021 A-share restricted stock incentive plan of shanghai haohai biological technology, cancellation of the unattributed restricted stocks that have been granted but not attributed, and achievement of the attribution conditions for the second attribution period of the reserved grant related matters.

HKEX · Nov 29 22:23

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

Risk Disclaimer

Statement